(Q33703334)

28 July 2017

1 reference

title

Benefits and risks of transfer from oral agents to insulin in type 2 diabetes mellitus (English)

1 reference

28 July 2017

1 reference

A Evans

1

1 reference

PubMed ID

10433350

28 July 2017

A J Krentz

series ordinal

2

1 reference

28 July 2017

1 July 1999

1 reference

28 July 2017

1 reference

28 July 2017

21

1 reference

28 July 2017

1

1 reference

28 July 2017

7-22

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199921010-00002

28 July 2017

0 references

cites work

Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).

1 reference

12 December 2020

Diabetes and cardiovascular disease. The "common soil" hypothesis

1 reference

12 December 2020

Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin

1 reference

12 December 2020

Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes

1 reference

12 December 2020

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

12 December 2020

Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group.

1 reference

12 December 2020

The combination of insulin and metformin in treatment of non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.

1 reference

12 December 2020

Insulin resistance, its consequences, and coronary heart disease. Must we choose one culprit?

1 reference

12 December 2020

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

1 reference

12 December 2020

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

1 reference

12 December 2020

New insulins and other possible therapeutic approaches

1 reference

12 December 2020

Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial

1 reference

12 December 2020

Diabetes care in South Asian and white European patients with type 2 diabetes

1 reference

12 December 2020

Why is insulin not a risk factor for coronary heart disease?

1 reference

12 December 2020

Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial

1 reference

12 December 2020

Non-insulin-dependent diabetes mellitus (NIDDM) in Asians in the UK

1 reference

12 December 2020

Carbohydrate metabolism in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes

1 reference

12 December 2020

Comparison of morning or bedtime insulin with and without glyburide in secondary sulfonylurea failure.

1 reference

12 December 2020

Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing?

1 reference

12 December 2020

Pathogenesis of non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Hyperinsulinemia and atherosclerosis

1 reference

12 December 2020

Comparison of different insulin regimens in elderly patients with NIDDM.

1 reference

12 December 2020

The effects of improved glycemic control on complications in type 2 diabetes

1 reference

12 December 2020

Intensive insulin therapy in type II diabetes: rationale and collaborative clinical trial results

1 reference

12 December 2020

Guidelines for good practice in the diagnosis and treatment of non-insulin-dependent diabetes mellitus. Report of a joint working party of the British Diabetic Association, the Research Unit of the Royal College of Physicians, and the Royal college

1 reference

12 December 2020

Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Morning or bedtime NPH insulin combined with sulfonylurea in treatment of NIDDM

1 reference

12 December 2020

Bedtime insulin/daytime glipizide. Effective therapy for sulfonylurea failures in NIDDM.

1 reference

12 December 2020

Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes

1 reference

12 December 2020

The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

12 December 2020

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

1 reference

12 December 2020

Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects

1 reference

12 December 2020

Insulin therapy in type 2 diabetic subjects suppresses plasminogen activator inhibitor (PAI-1) activity and proinsulin-like molecules independently of glycaemic control.

1 reference

12 December 2020

Hypertension in Diabetes Study (HDS): II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients

1 reference

12 December 2020

Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors.

1 reference

12 December 2020

Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes

1 reference

12 December 2020

Blood glucose control and microvascular and macrovascular complications in diabetes

1 reference

12 December 2020

Symptoms and well-being in relation to glycemic control in type II diabetes.

1 reference

12 December 2020

Managing diabetes after myocardial infarction

1 reference

12 December 2020

NIDDM and its metabolic control predict coronary heart disease in elderly subjects

1 reference

12 December 2020

1 reference

12 December 2020

Relation of glycemic control to diabetic microvascular complications in diabetes mellitus

1 reference

12 December 2020

Effect of exogenous hyperinsulinaemia on atherogenesis in cholesterol-fed rabbits

1 reference

12 December 2020

Preventive tolbutamide treatment and arterial disease in mild hyperglycaemia

1 reference

12 December 2020

United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.

1 reference

12 December 2020

Insulin use in NIDDM. Rationale based on pathophysiology of disease

1 reference

12 December 2020

Cardiovascular complications of diabetes mellitus: what we know and what we need to know about their prevention

1 reference

12 December 2020

Comparative tolerability profiles of oral antidiabetic agents

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Insulin for the non-insulin dependent?

1 reference

12 December 2020

Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.

1 reference

12 December 2020

Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus

1 reference

12 December 2020

A strategy for arterial risk assessment and management in type 2 (non-insulin-dependent) diabetes mellitus. European Arterial Risk Policy Group on behalf of the International Diabetes Federation European Region

1 reference

12 December 2020

Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis

1 reference

12 December 2020

Some answers, more controversy, from UKPDS. United Kingdom Prospective Diabetes Study

1 reference

12 December 2020

Preventing non-insulin-dependent diabetes

1 reference

12 December 2020

A summary of criticisms of the findings and conclusions of the University Group Diabetes Program (UGDP)

1 reference

12 December 2020

Why some cases of retinopathy worsen when diabetic control improves

1 reference

12 December 2020

Renal glucose production and utilization: new aspects in humans

1 reference

12 December 2020

Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation.

1 reference

12 December 2020

Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus

1 reference

12 December 2020

Dysglycaemia and risk of cardiovascular disease

1 reference

12 December 2020

NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance

1 reference

12 December 2020

Well-being and symptoms in relation to insulin therapy in type 2 diabetes.

1 reference

12 December 2020

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

12 December 2020

Management of non-insulin-dependent diabetes mellitus in Europe: a concensus view

1 reference

12 December 2020

Effect of intensive treatment of diabetes of the risk of death or renal failure in NIDDM and IDDM

1 reference

12 December 2020

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

12 December 2020

Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group

1 reference

12 December 2020

Relationship between insulin resistance and coronary heart disease in diabetes mellitus and the general population: a critical appraisal

1 reference

12 December 2020

Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM?

1 reference

12 December 2020

Learning to use troglitazone.

1 reference

12 December 2020

Bedtime insulin for suppression of overnight free-fatty acid, blood glucose, and glucose production in NIDDM

1 reference

12 December 2020

Insulin and sulfonylurea therapy in NIDDM patients. Are the effects on lipoprotein metabolism different even with similar blood glucose control?

1 reference

12 December 2020

Sustained good glycaemic control in NIDDM patients by implementation of structured care in general practice: 2-year follow-up study

1 reference

12 December 2020

10.2165/00002018-199921010-00002

Identifiers

DOI

1 reference

PubMed ID

10433350

Dimensions Publication ID

28 July 2017

0 references

1 reference

PubMed ID

10433350